Global Blood Plasma Derivatives Market Insights, Forecast to 2027
- Published Date : 06-09-2021
- Pages : 122
- Report Id : 54368
- Categories : Healthcare
This report studies the global market size of Blood Plasma Derivatives in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Blood Plasma Derivatives in these regions.
This research report categorizes the global Blood Plasma Derivatives market by top players/brands, region, type and end user. This report also studies the global Blood Plasma Derivatives market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
Blood plasma is the liquid component of blood constituting of water along with plasma components such as immunoglobulin, electrolytes, glucose, clotting factors, electrolytes, and hormones. It plays a crucial role in maintaining the electrolyte and osmotic balance while preventing infection and blood disorders in the body. Plasma derivatives are the concentrates of specific proteins, which require pooling of plasma from large number of donors. For instance, they require more than hundred plasma donations to produce sufficient immunoglobulin to treat an immune-deficient patient for one year. They are obtained by the process of fractionation where protein concentrates are separated and then clinically used.
The growth of the global blood plasma derivatives market is majorly driven by increase in prevalence of life-threatening disorders, especially hemophilia. Other factors boosting the market growth include rise in adoption of blood plasma derivatives products, upsurge in geriatric population across the world, and increase in awareness about blood & plasma donation. However, factors such as high cost of plasma derivative-based therapy and post-operative risks associated with plasma replacement therapy hamper the market growth. Conversely, the development of enhanced methods for preservation of plasma derivatives along with advanced procedures for fractionation and high potential in untapped markets in the emerging economies are expected to provide lucrative growth opportunities for the market.
The global Blood Plasma Derivatives market is valued at 24800 million US$ in 2020 and will reach 52000 million US$ by the end of 2027, growing at a CAGR of 9.7% during 2021-2027. The objectives of this study are to define, segment, and project the size of the Blood Plasma Derivatives market based on company, product type, end user and key regions.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Grifols, S.A.
SK Plasma Co., Ltd.
Fusion Health Care Pvt. Ltd.
Biotest AG
Green Cross Corporation
Baxter International Inc.
LFB S.A.
Octapharma AG
CSL Limited
Shire Plc.
China Biologic Products, Inc.
Kedrion Biopharma, Inc.
BDI Pharma, Inc.
Bayer AG
Hualan Biological Engineering, Inc.
Market size by Product
Albumin
Factor VIII
Factor IX
Immunoglobulin
Hyperimmune Globulin
Others
Market size by End User
Hospitals
Clinics
Other End Users
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Blood Plasma Derivatives market size (value & volume) by company, key regions, products and end user, breakdown data from 2013 to 2020, and forecast to 2027.
To understand the structure of Blood Plasma Derivatives market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Blood Plasma Derivatives companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Blood Plasma Derivatives submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Blood Plasma Derivatives are as follows:
History Year: 2016-2020
Base Year: 2020
Estimated Year: 2021
Forecast Year 2021 to 2027
This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Blood Plasma Derivatives market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2020 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
End of Summary
Table of Contents
1 Study Coverage
1.1 Blood Plasma Derivatives Product
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Blood Plasma Derivatives Market Size Growth Rate by Product
1.4.2 Albumin
1.4.3 Factor VIII
1.4.4 Factor IX
1.4.5 Immunoglobulin
1.4.6 Hyperimmune Globulin
1.4.7 Others
1.5 Market by End User
1.5.1 Global Blood Plasma Derivatives Market Size Growth Rate by End User
1.5.2 Hospitals
1.5.3 Clinics
1.5.4 Other End Users
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Blood Plasma Derivatives Market Size
2.1.1 Global Blood Plasma Derivatives Revenue 2016-2027
2.1.2 Global Blood Plasma Derivatives Sales 2016-2027
2.2 Blood Plasma Derivatives Growth Rate by Regions
2.2.1 Global Blood Plasma Derivatives Sales by Regions
2.2.2 Global Blood Plasma Derivatives Revenue by Regions
3 Breakdown Data by Manufacturers
3.1 Blood Plasma Derivatives Sales by Manufacturers
3.1.1 Blood Plasma Derivatives Sales by Manufacturers
3.1.2 Blood Plasma Derivatives Sales Market Share by Manufacturers
3.1.3 Global Blood Plasma Derivatives Market Concentration Ratio (CR5 and HHI)
3.2 Blood Plasma Derivatives Revenue by Manufacturers
3.2.1 Blood Plasma Derivatives Revenue by Manufacturers (2016-2021)
3.2.2 Blood Plasma Derivatives Revenue Share by Manufacturers (2016-2021)
3.3 Blood Plasma Derivatives Price by Manufacturers
3.4 Blood Plasma Derivatives Manufacturing Base Distribution, Product Types
3.4.1 Blood Plasma Derivatives Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Blood Plasma Derivatives Product Type
3.4.3 Date of International Manufacturers Enter into Blood Plasma Derivatives Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
4.1 Global Blood Plasma Derivatives Sales by Product
4.2 Global Blood Plasma Derivatives Revenue by Product
4.3 Blood Plasma Derivatives Price by Product
5 Breakdown Data by End User
5.1 Overview
5.2 Global Blood Plasma Derivatives Breakdown Data by End User
6 North America
6.1 North America Blood Plasma Derivatives by Countries
6.1.1 North America Blood Plasma Derivatives Sales by Countries
6.1.2 North America Blood Plasma Derivatives Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Blood Plasma Derivatives by Product
6.3 North America Blood Plasma Derivatives by End User
7 Europe
7.1 Europe Blood Plasma Derivatives by Countries
7.1.1 Europe Blood Plasma Derivatives Sales by Countries
7.1.2 Europe Blood Plasma Derivatives Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Blood Plasma Derivatives by Product
7.3 Europe Blood Plasma Derivatives by End User
8 Asia Pacific
8.1 Asia Pacific Blood Plasma Derivatives by Countries
8.1.1 Asia Pacific Blood Plasma Derivatives Sales by Countries
8.1.2 Asia Pacific Blood Plasma Derivatives Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Blood Plasma Derivatives by Product
8.3 Asia Pacific Blood Plasma Derivatives by End User
9 Central & South America
9.1 Central & South America Blood Plasma Derivatives by Countries
9.1.1 Central & South America Blood Plasma Derivatives Sales by Countries
9.1.2 Central & South America Blood Plasma Derivatives Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Blood Plasma Derivatives by Product
9.3 Central & South America Blood Plasma Derivatives by End User
10 Middle East and Africa
10.1 Middle East and Africa Blood Plasma Derivatives by Countries
10.1.1 Middle East and Africa Blood Plasma Derivatives Sales by Countries
10.1.2 Middle East and Africa Blood Plasma Derivatives Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Blood Plasma Derivatives by Product
10.3 Middle East and Africa Blood Plasma Derivatives by End User
11 Company Profiles
11.1 Grifols, S.A.
11.1.1 Grifols, S.A. Company Details
11.1.2 Company Business Overview
11.1.3 Grifols, S.A. Blood Plasma Derivatives Sales, Revenue and Gross Margin (2016-2021)
11.1.4 Grifols, S.A. Blood Plasma Derivatives Products Offered
11.1.5 Grifols, S.A. Recent Development
11.2 SK Plasma Co., Ltd.
11.2.1 SK Plasma Co., Ltd. Company Details
11.2.2 Company Business Overview
11.2.3 SK Plasma Co., Ltd. Blood Plasma Derivatives Sales, Revenue and Gross Margin (2016-2021)
11.2.4 SK Plasma Co., Ltd. Blood Plasma Derivatives Products Offered
11.2.5 SK Plasma Co., Ltd. Recent Development
11.3 Fusion Health Care Pvt. Ltd.
11.3.1 Fusion Health Care Pvt. Ltd. Company Details
11.3.2 Company Business Overview
11.3.Fusion Health Care Pvt. Ltd. Blood Plasma Derivatives Sales, Revenue and Gross Margin (2016-2021)
11.3.4 Fusion Health Care Pvt. Ltd. Blood Plasma Derivatives Products Offered
11.3.5 Fusion Health Care Pvt. Ltd. Recent Development
11.4 Biotest AG
11.4.1 Biotest AG Company Details
11.4.2 Company Business Overview
11.4.3 Biotest AG Blood Plasma Derivatives Sales, Revenue and Gross Margin (2016-2021)
11.4.4 Biotest AG Blood Plasma Derivatives Products Offered
11.4.5 Biotest AG Recent Development
11.5 Green Cross Corporation
11.5.1 Green Cross Corporation Company Details
11.5.2 Company Business Overview
11.5.3 Green Cross Corporation Blood Plasma Derivatives Sales, Revenue and Gross Margin (2016-2021)
11.5.4 Green Cross Corporation Blood Plasma Derivatives Products Offered
11.5.5 Green Cross Corporation Recent Development
11.6 Baxter International Inc.
11.6.1 Baxter International Inc. Company Details
11.6.2 Company Business Overview
11.6.3 Baxter International Inc. Blood Plasma Derivatives Sales, Revenue and Gross Margin (2016-2021)
11.6.4 Baxter International Inc. Blood Plasma Derivatives Products Offered
11.6.5 Baxter International Inc. Recent Development
11.7 LFB S.A.
11.7.1 LFB S.A. Company Details
11.7.2 Company Business Overview
11.7.3 LFB S.A. Blood Plasma Derivatives Sales, Revenue and Gross Margin (2016-2021)
11.7.4 LFB S.A. Blood Plasma Derivatives Products Offered
11.7.5 LFB S.A. Recent Development
11.8 Octapharma AG
11.8.1 Octapharma AG Company Details
11.8.2 Company Business Overview
11.8.3 Octapharma AG Blood Plasma Derivatives Sales, Revenue and Gross Margin (2016-2021)
11.8.4 Octapharma AG Blood Plasma Derivatives Products Offered
11.8.5 Octapharma AG Recent Development
11.9 CSL Limited
11.9.1 CSL Limited Company Details
11.9.2 Company Business Overview
11.9.3 CSL Limited Blood Plasma Derivatives Sales, Revenue and Gross Margin (2016-2021)
11.9.4 CSL Limited Blood Plasma Derivatives Products Offered
11.9.5 CSL Limited Recent Development
11.10 Shire Plc.
11.10.1 Shire Plc. Company Details
11.10.2 Company Business Overview
11.10.3 Shire Plc. Blood Plasma Derivatives Sales, Revenue and Gross Margin (2016-2021)
11.10.4 Shire Plc. Blood Plasma Derivatives Products Offered
11.10.5 Shire Plc. Recent Development
11.11 China Biologic Products, Inc.
11.12 Kedrion Biopharma, Inc.
11.13 BDI Pharma, Inc.
11.14 Bayer AG
11.15 Hualan Biological Engineering, Inc.
12 Future Forecast
12.1 Blood Plasma Derivatives Market Forecast by Regions
12.1.1 Global Blood Plasma Derivatives Sales Forecast by Regions 2021-2027
12.1.2 Global Blood Plasma Derivatives Revenue Forecast by Regions 2021-2027
12.2 Blood Plasma Derivatives Market Forecast by Product
12.2.1 Global Blood Plasma Derivatives Sales Forecast by Product 2021-2027
12.2.2 Global Blood Plasma Derivatives Revenue Forecast by Product 2021-2027
12.3 Blood Plasma Derivatives Market Forecast by End User
12.4 North America Blood Plasma Derivatives Forecast
12.5 Europe Blood Plasma Derivatives Forecast
12.6 Asia Pacific Blood Plasma Derivatives Forecast
12.7 Central & South America Blood Plasma Derivatives Forecast
12.8 Middle East and Africa Blood Plasma Derivatives Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Blood Plasma Derivatives Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables and Figures
Figure Blood Plasma Derivatives Product Picture
Table Blood Plasma Derivatives Market Segments
Table Key Manufacturers Blood Plasma Derivatives Covered
Table Global Blood Plasma Derivatives Market Size Growth Rate by Product 2021-2027 (K Units) & (Million US$)
Figure Global Blood Plasma Derivatives Sales Market Share by Product 2016-2027
Figure Albumin Product Picture
Table Major Manufacturers of Albumin
Figure Factor VIII Product Picture
Table Major Manufacturers of Factor VIII
Figure Factor IX Product Picture
Table Major Manufacturers of Factor IX
Figure Immunoglobulin Product Picture
Table Major Manufacturers of Immunoglobulin
Figure Hyperimmune Globulin Product Picture
Table Major Manufacturers of Hyperimmune Globulin
Figure Others Product Picture
Table Major Manufacturers of Others
Table Global Blood Plasma Derivatives Market Size Growth Rate by End User 2021-2027 (K Units)
Figure Hospitals
Figure Clinics
Figure Other End Users
Figure Blood Plasma Derivatives Report Years Considered
Figure Global Blood Plasma Derivatives Market Size 2016-2027 (Million US$)
Figure Global Blood Plasma Derivatives Sales 2016-2027 (K Units)
Table Global Blood Plasma Derivatives Market Size by Regions 2016-2021 (K Units) & (Million US$)
Table Global Blood Plasma Derivatives Sales by Regions 2016-2021 (K Units)
Table Global Blood Plasma Derivatives Sales Market Share by Regions 2016-2021
Figure Global Blood Plasma Derivatives Sales Market Share by Regions 2016-2021
Figure 2020 Global Blood Plasma Derivatives Sales Market Share by Regions
Table Global Blood Plasma Derivatives Revenue by Regions 2016-2021 (Million US$)
Table Global Blood Plasma Derivatives Revenue Market Share by Regions 2016-2021
Figure Global Blood Plasma Derivatives Revenue Market Share by Regions 2016-2021
Figure 2020 Global Blood Plasma Derivatives Revenue Market Share by Regions
Table Global Blood Plasma Derivatives Sales by Manufacturers (2016-2021) (K Units)
Table Global Blood Plasma Derivatives Sales Share by Manufacturers (2016-2021)
Figure Global Blood Plasma Derivatives Sales Share by Manufacturers in 2020
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Blood Plasma Derivatives Revenue by Manufacturers (2016-2021) (Million USD)
Table Blood Plasma Derivatives Revenue Share by Manufacturers (2016-2021)
Figure Blood Plasma Derivatives Value Share by Manufacturers in 2020
Table Key Manufacturers Blood Plasma Derivatives Price (2016-2021) (USD/Unit)
Table Blood Plasma Derivatives Manufacturers Manufacturing Base Distribution and Headquarters
Table Manufacturers Blood Plasma Derivatives Product Type
Table Date of International Manufacturers Enter into Blood Plasma Derivatives Market
Table Manufacturers Mergers & Acquisitions, Expansion Plans
Table Global Blood Plasma Derivatives Sales by Product (2016-2021) (K Units)
Table Global Blood Plasma Derivatives Sales Share by Product (2016-2021)
Figure Global Blood Plasma Derivatives Sales Market Share by Product (2016-2021)
Figure Global Blood Plasma Derivatives Sales Market Share by Product in 2020
Table Global Blood Plasma Derivatives Revenue by Product (2016-2021) (Million US$)
Table Global Blood Plasma Derivatives Revenue Share by Product (2016-2021)
Figure Global Blood Plasma Derivatives Revenue Market Share by Product (2016-2021)
Figure Global Blood Plasma Derivatives Revenue Market Share by Product in 2020
Table Blood Plasma Derivatives Price by Product 2016-2021 (USD/Unit)
Table Global Blood Plasma Derivatives Sales by End User (2016-2021) (K Units)
Table Global Blood Plasma Derivatives Sales Share by End User (2016-2021)
Figure Global Sales Blood Plasma Derivatives Market Share by End User (2016-2021)
Figure Global Sales Blood Plasma Derivatives Market Share by End User in 2020
Figure North America Blood Plasma Derivatives Sales Growth Rate 2016-2021 (K Units)
Figure North America Blood Plasma Derivatives Revenue Growth Rate 2016-2021 (Million US$)
Table North America Blood Plasma Derivatives Sales by Countries (2016-2021) (K Units)
Table North America Blood Plasma Derivatives Sales Market Share by Countries (2016-2021)
Figure 2020 North America Blood Plasma Derivatives Sales Market Share by Countries
Table North America Blood Plasma Derivatives Revenue by Countries (2016-2021) (Million US$)
Table North America Blood Plasma Derivatives Revenue Market Share by Countries (2016-2021)
Figure 2020 North America Blood Plasma Derivatives Revenue Market Share by Countries
Figure United States Blood Plasma Derivatives Sales Growth Rate (2016-2021) (K Units)
Figure United States Blood Plasma Derivatives Revenue Growth Rate (2016-2021) (K Units)
Figure Canada Blood Plasma Derivatives Sales Growth Rate (2016-2021) (K Units)
Figure Canada Blood Plasma Derivatives Revenue Growth Rate (2016-2021) (Million US$)
Figure Mexico Blood Plasma Derivatives Sales Growth Rate (2016-2021) (K Units)
Figure Mexico Blood Plasma Derivatives Revenue Growth Rate (2016-2021) (Million US$)
Table North America Blood Plasma Derivatives Sales by Product (2016-2021) (K Units)
Table North America Blood Plasma Derivatives Sales Market Share by Product (2016-2021)
Figure 2020 North America Blood Plasma Derivatives Market Share by Product
Table North America Blood Plasma Derivatives Sales by End User (2016-2021) (K Units)
Table North America Blood Plasma Derivatives Sales Market Share by End User (2016-2021)
Figure 2020 North America Blood Plasma Derivatives Market Share by End User
Figure Europe Blood Plasma Derivatives Sales Growth Rate 2016-2021 (K Units)
Figure Europe Blood Plasma Derivatives Revenue Growth Rate 2016-2021 (Million US$)
Table Europe Blood Plasma Derivatives Sales by Countries (2016-2021) (K Units)
Table Europe Blood Plasma Derivatives Sales Market Share by Countries (2016-2021)
Figure 2020 Europe Blood Plasma Derivatives Sales Market Share by Countries
Table Europe Blood Plasma Derivatives Revenue by Countries (2016-2021) (Million US$)
Table Europe Blood Plasma Derivatives Revenue Market Share by Countries (2016-2021)
Figure 2020 Europe Blood Plasma Derivatives Revenue Market Share by Countries
Figure Germany Blood Plasma Derivatives Sales Growth Rate (2016-2021) (K Units)
Figure Germany Blood Plasma Derivatives Revenue Growth Rate (2016-2021) (Million US$)
Figure France Blood Plasma Derivatives Sales Growth Rate (2016-2021) (K Units)
Figure France Blood Plasma Derivatives Revenue Growth Rate (2016-2021) (Million US$)
Figure UK Blood Plasma Derivatives Sales Growth Rate (2016-2021) (K Units)
Figure UK Blood Plasma Derivatives Revenue Growth Rate (2016-2021) (Million US$)
Figure Italy Blood Plasma Derivatives Sales Growth Rate (2016-2021) (K Units)
Figure Italy Blood Plasma Derivatives Revenue Growth Rate (2016-2021) (Million US$)
Figure Russia Blood Plasma Derivatives Sales Growth Rate (2016-2021) (K Units)
Figure Russia Blood Plasma Derivatives Revenue Growth Rate (2016-2021) (Million US$)
Table Europe Blood Plasma Derivatives Sales by Product (2016-2021) (K Units)
Table Europe Blood Plasma Derivatives Sales Market Share by Product (2016-2021)
Figure 2020 Europe Blood Plasma Derivatives Market Share by Product
Table Europe Blood Plasma Derivatives Sales by End User (2016-2021) (K Units)
Table Europe Blood Plasma Derivatives Sales Market Share by End User (2016-2021)
Figure 2020 Europe Blood Plasma Derivatives Market Share by End User
Figure Asia Pacific Blood Plasma Derivatives Sales Growth Rate 2016-2021 (K Units)
Figure Asia Pacific Blood Plasma Derivatives Revenue Growth Rate 2016-2021 (Million US$)
Table Asia Pacific Blood Plasma Derivatives Sales by Countries (2016-2021) (K Units)
Table Asia Pacific Blood Plasma Derivatives Sales Market Share by Countries (2016-2021)
Figure 2020 Asia Pacific Blood Plasma Derivatives Sales Market Share by Countries
Table Asia Pacific Blood Plasma Derivatives Revenue by Countries (2016-2021) (Million US$)
Table Asia Pacific Blood Plasma Derivatives Revenue Market Share by Countries (2016-2021)
Figure 2020 Asia Pacific Blood Plasma Derivatives Revenue Market Share by Countries
Figure China Blood Plasma Derivatives Sales Growth Rate (2016-2021) (K Units)
Figure China Blood Plasma Derivatives Revenue Growth Rate (2016-2021) (Million US$)
Figure Japan Blood Plasma Derivatives Sales Growth Rate (2016-2021) (K Units)
Figure Japan Blood Plasma Derivatives Revenue Growth Rate (2016-2021) (Million US$)
Figure Korea Blood Plasma Derivatives Sales Growth Rate (2016-2021) (K Units)
Figure Korea Blood Plasma Derivatives Revenue Growth Rate (2016-2021) (Million US$)
Figure India Blood Plasma Derivatives Sales Growth Rate (2016-2021) (K Units)
Figure India Blood Plasma Derivatives Revenue Growth Rate (2016-2021) (Million US$)
Figure Australia Blood Plasma Derivatives Sales Growth Rate (2016-2021) (K Units)
Figure Australia Blood Plasma Derivatives Revenue Growth Rate (2016-2021) (Million US$)
Figure Indonesia Blood Plasma Derivatives Sales Growth Rate (2016-2021) (K Units)
Figure Indonesia Blood Plasma Derivatives Revenue Growth Rate (2016-2021) (Million US$)
Figure Malaysia Blood Plasma Derivatives Sales Growth Rate (2016-2021) (K Units)
Figure Malaysia Blood Plasma Derivatives Revenue Growth Rate (2016-2021) (Million US$)
Figure Philippines Blood Plasma Derivatives Sales Growth Rate (2016-2021) (K Units)
Figure Philippines Blood Plasma Derivatives Revenue Growth Rate (2016-2021) (Million US$)
Figure Thailand Blood Plasma Derivatives Sales Growth Rate (2016-2021) (K Units)
Figure Thailand Blood Plasma Derivatives Revenue Growth Rate (2016-2021) (Million US$)
Figure Vietnam Blood Plasma Derivatives Sales Growth Rate (2016-2021) (K Units)
Figure Vietnam Blood Plasma Derivatives Revenue Growth Rate (2016-2021) (Million US$)
Figure Singapore Blood Plasma
Direct Purchase
Your perfect start with Research AlliedWant to customize this report?
This report can be customized according to your requirements. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time.
Avail PDF Sample Reports
You may also be lnterested in..
Research Allied Copyright © 2024 .